Can human chorionic gonadotropin (hCG) raise follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) levels and produce falsely high assay results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

hCG Does Not Increase FSH or LH—Rather, the Reverse Occurs: LH Cross-Reacts with hCG Assays

The question is backwards: hCG does not raise FSH and LH levels. Instead, elevated LH (particularly in hypogonadal states) can cross-react with hCG immunoassays and produce falsely elevated hCG readings. 1

The Actual Mechanism of False-Positive Results

LH Cross-Reactivity with hCG Assays

  • LH can cross-react with some hCG immunoassays because hCG and LH share an identical alpha subunit and have structural similarities. 1, 2

  • This cross-reactivity is particularly problematic in hypogonadal patients (such as those post-orchiectomy or post-chemotherapy) who develop compensatory elevations in pituitary LH and FSH secretion. 1

  • The American Society of Clinical Oncology guidelines specifically warn that "unilateral orchiectomy and chemotherapy can cause low testosterone levels, which in turn can lead to increased production of LH and hCG by the pituitary gland. LH can cross-react with some assays for hCG." 1

Clinical Evidence of the Problem

  • In men with solitary or absent testes, 41% had falsely positive commercial hCG determinations due to elevated LH levels and cross-reactivity. 3

  • There was a striking correlation between elevated serum LH levels and falsely elevated commercial hCG levels in men with gonadal dysfunction. 3

  • Falsely elevated hCG values (1.7-7.8 mIU/ml) occurred in patients with complete tumor response who had simultaneously elevated LH (18-79.9 mIU/ml) and FSH (5-80 mIU/ml) due to iatrogenic hypogonadism. 4

What Actually Happens When hCG is Administered

hCG Suppresses FSH, Not the Reverse

  • When hCG levels exceed 100 U/L, subtotal inhibition of FSH secretion occurs. 5

  • In patients treated with GnRH agonists plus hMG, exogenous hCG administration led to a significant fall in LH levels, not a rise. 6

  • hCG acts like LH to stimulate testosterone production, which through negative feedback suppresses pituitary gonadotropin release. 1

Clinical Management of This Assay Interference

How to Identify False-Positive hCG

  • Check FSH levels from the same serum sample. If beta-hCG is elevated but FSH is also excessively elevated (>50 U/L), the hCG elevation may be due to LH cross-reactivity rather than tumor. 5

  • Administer supplemental testosterone to hypogonadal patients, which reduces gonadotropin-releasing hormone and consequently suppresses pituitary production of LH and hCG, normalizing the falsely elevated hCG reading. 1, 4

  • Each laboratory should establish the degree of cross-reactivity with their specific gonadotropin assay, and physicians should inform the laboratory when patients are on hCG therapy if gonadotropin levels are requested. 2

Common Pitfall to Avoid

  • Do not assume mildly elevated hCG (especially <10 mIU/ml) represents tumor recurrence in post-treatment germ cell tumor patients with hypogonadism without first checking LH/FSH levels and considering assay cross-reactivity. 5, 4, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.